Trial Profile

A Randomized Open-label Trial Cross-over Trial of Iron Isomaltoside 1000 (Monofer) Compared With Iron Sucrose (Venofer) in Peritoneal Dialysis Patients

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ferric derisomaltose (Primary) ; Iron sucrose
Indications Iron deficiency anaemia
Focus Therapeutic Use

Most Recent Events

28 Sep 2021 Status changed from recruiting to discontinued as there is difficulty in patient recruitment due to COVID-19 epidemic
30 Apr 2019 Status changed from not yet recruiting to recruiting.
07 Aug 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com